Natera is trading at $342.54, up +4.14% on September 14, 2026, outperforming the broader market as major indexes are lower.
- Management presented growth opportunities at the Morgan Stanley healthcare conference, including oncology, women’s health, Latitude, and early cancer detection.
- The report does not explicitly link those comments to the share-price move.
- No separate same-day announcement or analyst action was identified.